Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Halevy

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2006
Relevance of aluminum screening in 2006Daniel Halevy
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2007
Is a target hemoglobin A1c below 7% safe in dialysis patients?Daniel Halevy, Madhavi Vemireddy
Critical Care Clinics|June 11, 2002
Thrombotic microangiopathiesDaniel Halevy, Jai Radhakrishnan, Glen Markowitz, et al.
The International Journal of Lower Extremity Wounds|March 25, 2014
Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic footAndreas Ambrosch, Daniel Halevy, Boushra Fwity, et al.
The International Journal of Lower Extremity Wounds|June 18, 2013
Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic footAndreas Ambrosch, Daniel Halevy, Boushra Fwity, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2006
Relevance of aluminum screening in 2006Daniel Halevy
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2007
Is a target hemoglobin A1c below 7% safe in dialysis patients?Daniel Halevy, Madhavi Vemireddy
Critical Care Clinics|June 11, 2002
Thrombotic microangiopathiesDaniel Halevy, Jai Radhakrishnan, Glen Markowitz, et al.
The International Journal of Lower Extremity Wounds|March 25, 2014
Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic footAndreas Ambrosch, Daniel Halevy, Boushra Fwity, et al.
The International Journal of Lower Extremity Wounds|June 18, 2013
Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic footAndreas Ambrosch, Daniel Halevy, Boushra Fwity, et al.
Pageof 1